OTC Tax Deductibility Is Capital Issue At CHPA Conference In D.C.
This article was originally published in The Tan Sheet
Executive Summary
CHPA is planning a March 16 board meeting on Capitol Hill featuring several key members of Congress as a precursor to the trade group's annual meeting in Washington, D.C
You may also be interested in...
OTCs Would Be Tax Deductible Under House Bill; Supplement Status Unclear
A bill to make nonprescription drugs qualify as deductible medical expenses would make the law evenhanded to consumers using OTCs for chronic conditions, sponsor Rep. Jim DeMint (R-S.C.) says
IRS Rule On Flex-Spending Accounts A Boon For Chronic-Use OTCs, Switches
Schering-Plough's Claritin and Procter & Gamble's Prilosec OTC are likely to be major beneficiaries of an IRS ruling that nonprescription drugs can be covered by employee health flexible spending arrangements
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC